C-TRI Overview
- Founded
- 1998

- Status
- Acquired/Merged
- Employees
- 135

- Latest Deal Type
- M&A
- Financing Rounds
- 3
- Investments
- 1
C-TRI General Information
Description
Mediforum Pharmaceutical Inc Inc is a research-oriented pharmaceutical company. It is engaged in developing Peptide drugs, Antiviral drugs and Ionic liquids. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and others.
Contact Information
(Operating Subsidiary)
- 778-1 Ilpaedong
- Gyeonggangro, Gyeonggi-do
- Namyangiu, 472-930
- South Korea
C-TRI Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore C-TRI‘s full profile, request access.
Request a free trialC-TRI Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Wan-joo Kim | Founder, President & Chief Executive Officer |
C-TRI Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialC-TRI Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore C-TRI‘s full profile, request access.
Request a free trialC-TRI Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000 0000000 | 07-Apr-2020 | 000000000 | 000 | Pharmaceuticals |